|
MSL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97420000347392E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06199946006791E-10 |
| Normal-vs-Stage2 |
2.32619999999129E-05 |
| Normal-vs-Stage3 |
3.86050003076122E-09 |
| Normal-vs-Stage4 |
7.2639999570967E-09 |
| Stage1-vs-Stage2 |
7.975000E-01 |
| Stage1-vs-Stage3 |
9.753700E-02 |
| Stage1-vs-Stage4 |
9.789900E-02 |
| Stage2-vs-Stage3 |
1.638620E-01 |
| Stage2-vs-Stage4 |
1.201640E-01 |
| Stage3-vs-Stage4 |
6.942400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.63149995922186E-09 |
| Normal-vs-AfricanAmerican |
2.041400E-03 |
| Normal-vs-Asian |
4.95790000054619E-07 |
| Caucasian-vs-AfricanAmerican |
2.696600E-01 |
| Caucasian-vs-Asian |
5.335400E-01 |
| AfricanAmerican-vs-Asian |
4.756400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23029999965496E-07 |
| Normal-vs-Female |
1.84699999739024E-08 |
| Male-vs-Female |
7.432400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.24750004665475E-09 |
| Normal-vs-Age(41-60Yrs) |
1.85799999830039E-08 |
| Normal-vs-Age(61-80Yrs) |
9.38049999898993E-08 |
| Normal-vs-Age(81-100Yrs) |
4.122400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.908200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.764600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.685000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.776800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.323800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.400900E-04 |
| Classical-VS-Follicular |
1.206420E-01 |
| Classical-VS-Other |
3.762400E-01 |
| Classical-VS-Normal |
7.95449999979603E-07 |
| Tall-VS-Follicular |
2.985700E-02 |
| Tall-VS-Other |
3.797400E-01 |
| Tall-VS-Normal |
1.25179977494838E-10 |
| Follicular-VS-Other |
7.329000E-01 |
| Follicular-VS-Normal |
9.60830004448354E-09 |
| Other-VS-Normal |
9.435300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61989999694734E-08 |
| Normal-vs-N1 |
2.47180054202545E-10 |
| N0-vs-N1 |
3.042400E-02 |
|
|
